1	Iniciar	iniciar	VMN0000	-	-	0-7	144(4)_ANS_clinical_caseMIR	SENT1	-	-
2	tratamiento	tratamiento	NCMS000	C1273870#C0087111	procedimiento#r√©gimen/tratamiento	8-19	144(4)_ANS_clinical_caseMIR	SENT1	-	-
3	con	con	SPS00	C0332287	atributo	20-23	144(4)_ANS_clinical_caseMIR	SENT1	-	-
4	rifampicina	rifampicina	NCFS000	C0035608	sustancia	24-35	144(4)_ANS_clinical_caseMIR	SENT1	B-Grp_Medicamento	-
5	y	y	CC	C1706368	calificador	36-37	144(4)_ANS_clinical_caseMIR	SENT1	-	-
6	pirazinamida	pirazinamida	NC00SC0	C0034239	sustancia	38-50	144(4)_ANS_clinical_caseMIR	SENT1	B-Grp_Medicamento	-
7	durante	durante	SPS00	C1444752#C0347984	atributo	51-58	144(4)_ANS_clinical_caseMIR	SENT1	-	-
8	9	9		-	-	59-60	144(4)_ANS_clinical_caseMIR	SENT1	-	-
9	meses	mes	NCMP000	C0439231	calificador	61-66	144(4)_ANS_clinical_caseMIR	SENT1	-	-
10	.	.	Fp	-	-	66-67	144(4)_ANS_clinical_caseMIR	SENT1	-	-

